Exchange: NASDAQ·Updated 06:40 AM EDT
PRFX logo

PRFX PainReform Ltd

$0.95
$0.0292
(2.98%)
Pre-Market
Prev Close $0.9792
Mkt Cap$2.96M
Vol5,860.00

About PRFX

PRF Technologies Ltd. is a pharmaceutical company, which focuses on reformulation of established therapeutics. It offers PRF-110, an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed prior to closure to provide localized and extended post-operative analgesia. The company was founded by Lihu Avitov and Dan Teleman in 2007 and is headquartered in Herzliya, Israel.
74

Bullish Sentiment

How do you feel about PRFX?

Advertisement|Remove ads.